ABT,Justice dept alleges Omnicare received kickbacks from Abbott Labs Dec 22 The U.S. Justice Department has filed a complaint against Omnicare Inc, alleging that the largest U.S. provider of pharmacy services to the elderly received millions of dollars in kickbacks from Abbott Laboratories. ~U.S. regulator charges two with insider trading in Abbott deal NEW YORK/SANTIAGO A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year. ~U.S. regulator charges two Chileans with insider trading NEW YORK/SANTIAGO A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories’ $2.9 billion acquisition of CFR earlier this year. ~UPDATE 1-U.S. regulator charges two Chileans with insider trading NEW YORK/SANTIAGO A former board member of Chile's CFR Pharmaceuticals SA was charged on Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year. ~U.S. regulator charges two with insider trading in Abbott deal NEW YORK/SANTIAGO A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories’ $2.9 billion acquisition of CFR earlier this year. ~U.S. regulator charges two with insider trading in Abbott deal NEW YORK/SANTIAGO, Dec 22 A former board member of Chile's CFR Pharmaceuticals SA was charged Monday by U.S. regulators with insider trading on information regarding Abbott Laboratories' $2.9 billion acquisition of CFR earlier this year. ~
ABBV.N,US STOCKS-Dow, S&P; end at records in 4th straight day of gains for Wall St * Dow boosted by gains at Intel, IBM; Dow, S&P; end at record ~US STOCKS-Wall St up for fourth straight day; S&P; ends at record * Indexes up: Dow 0.9 pct, S&P; 0.4 pct, Nasdaq 0.3 pct   (Updates to close) ~UPDATE 3-Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival Dec 22 The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's  newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's  treatments after trying for nearly a year to win a deeper discount. ~UPDATE 2-Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment   ~US STOCKS-Wall St on track for four-day rally; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates prices) ~US STOCKS-Wall St edges up after three-day run; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to afternoon trading) ~Achillion data shows promise of shorter-duration hep C treatment Data from Achillion Pharmaceuticals Inc's hepatitis C drug trials showed the company could develop a shorter-duration treatment rivaling offerings from Gilead Sciences Inc and Abbvie Inc. ~UPDATE 1-Achillion data shows promise of shorter-duration hep C treatment * Achillion's NS5A inhibitor superior to Gilead's - analysts ~REFILE-US STOCKS-Wall St edges up after three-day run; Gilead slumps * Indexes up: Dow 0.48 pct, S&P; 0.13 pct, Nasdaq 0.24 pct ~
BA,Air China signs deal to purchase 60 Boeing B737 aircraft BEIJING, Dec 22 Air China Ltd, the country's flag carrier, said Monday it signed an agreement to order 60 Boeing B737 planes for a total price of $5.9 billion. ~BRIEF-Air China, unit sign agreement to order 60 Boeing B737 planes * Says it and unit sign agreement to order 60 Boeing B737 aircrafts ~BRIEF-India's Vistara says open to taking Boeing planes for fleet beyond 2017 * India's Vistara exec says open to taking Boeing Co  planes for fleet beyond 2017 ~RPT-INSIGHT-Flying back on course: the inside story of the new Airbus A350 jet PARIS, Dec 21 Ten years ago, the boss of Qatar Airways, who takes his first new A350 jet this week, warned Airbus it was flying off course. ~
BMY,UPDATE 1-FDA approves Bristol-Myers' immunotherapy for skin cancer Dec 22 The U.S. Food and Drug Administration approved Bristol-Myers Squibb Co's skin cancer drug, more than three months before the scheduled review date. ~FDA approves Bristol-Myer's skin cancer drug Dec 22 The U.S. Food and Drug Administration granted an accelerated approval to Bristol-Myers Squibb Co's  drug for an advanced form of skin cancer. ~
C,ON THE MOVE-Former Deutsche advisers in Texas go independent Dec 22 A team of financial advisers from Texas that left Deutsche Asset & Wealth Management launched their own independent advisory firm and will use Dynasty Financial Partners' wealth management platform, Dynasty said on Monday. ~
CME.O,CME pursues EU wheat plan as Euronext dogged by harvest fallout   ~CME pursues EU wheat plan as Euronext dogged by harvest fallout * French grain coops ask CME to hone EU wheat futures plan ~
CMCSA.O,UPDATE 1-U.S. FCC pauses Comcast-Time Warner merger review until Jan. 12 WASHINGTON U.S. Federal Communications Commission on Monday once again paused its review of the proposed $45 billion merger of Comcast Corp and Time Warner Cable Inc, citing delays in getting documents from Time Warner Cable. ~U.S. FCC pauses Comcast-Time Warner merger review until January 12 WASHINGTON U.S. Federal Communications Commission on Monday once again paused its review of the proposed $45 billion merger of Comcast Corp and Time Warner Cable Inc, citing delays in getting documents from Time Warner Cable. ~UPDATE 1-U.S. FCC pauses Comcast-Time Warner merger review until Jan. 12 (Adds comments from Time Warner Cable and Comcast, background) ~U.S. FCC pauses Comcast-Time Warner merger review until Jan. 12 WASHINGTON, Dec 22 U.S. Federal Communications Commission on Monday paused until January 12 its informal 180-day countdown for the review of the proposed $45 billion merger of Comcast Corp and Time Warner Cable Inc  over delays in document submission. ~
ESRX.O,US STOCKS-Dow, S&P; end at records in 4th straight day of gains for Wall St * Dow boosted by gains at Intel, IBM; Dow, S&P; end at record ~US STOCKS-Wall St up for fourth straight day; S&P; ends at record * Indexes up: Dow 0.9 pct, S&P; 0.4 pct, Nasdaq 0.3 pct   (Updates to close) ~UPDATE 3-Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival Dec 22 The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's  newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's  treatments after trying for nearly a year to win a deeper discount. ~UPDATE 2-Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment   ~US STOCKS-Wall St on track for four-day rally; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates prices) ~US STOCKS-Wall St edges up after three-day run; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to afternoon trading) ~US STOCKS-Wall St flat after three-day run; Gilead drags * Indexes: Dow up 0.39 pct, S&P; off 0.01 pct, Nasdaq up 0.04 pct ~REFILE-US STOCKS-Wall St edges up after three-day run; Gilead slumps * Indexes up: Dow 0.48 pct, S&P; 0.13 pct, Nasdaq 0.24 pct ~US STOCKS-Wall St set to open up after three-day run; data on tap * Biocryst gets FDA OK for intravenous flu drug   (Adds quote, updates prices) ~
XOM,COLUMN-Sell your investment losers for a holiday tax present (The opinions expressed here are those of the author, a columnist for Reuters.) ~
GE,UK adds to Alstom's legal woes as power unit faces bribe charge LONDON/PARIS, Dec 22 Britain's Serious Fraud Office (SFO) has charged a British subsidiary of French energy equipment firm Alstom with bribing officials to secure a power contract, making it the second Alstom unit to face UK charges this year. ~
GM,GM gets 104 more claims for faulty ignition switch compensation General Motors Co  has received 104 claims for compensation for ignition switch defects in its cars in the past week, bringing the total to 2,430, according to the official administering the compensation program. ~GM gets 104 more claims for faulty ignition switch compensation Dec 22 General Motors Co has received 104 claims for compensation for ignition switch defects in its cars in the past week, bringing the total to 2,430, according to the official administering the compensation program. ~RPT-Optimistic 2015 HY outlook despite energy headwinds (Repeats to reach additional subscribers)     By Mariana Santibanez     NEW YORK, Dec 18 (IFR) - The energy sell-off has muddled the outlook for high-yield bonds, but things don't look too gloomy overall for 2015, as issuers will still have access to capital - and defaults shouldn't be too bad.     Without question, the asset class has been hammered of late. Spreads on energy bonds have widened 148bp to 841bp over US Treasuries in the last two weeks, according to Bank of America Merrill Lynch da ~
GILD.O,US STOCKS-Wall St up for fourth straight day; S&P; ends at record * Indexes up: Dow 0.9 pct, S&P; 0.4 pct, Nasdaq 0.3 pct   (Updates to close) ~UPDATE 3-Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival Dec 22 The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's  newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's  treatments after trying for nearly a year to win a deeper discount. ~UPDATE 2-Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment   ~GLOBAL MARKETS-Shares higher on year-end buying, ECB stimulus hints * U.S. shares higher on year-end buying     * ECB QE hopes, Greek political relief boost European shares     * Gilead weighs on S&P;, Nasdaq 100     * Oil prices resume declines   (Adds close of European stock markets, investor quote, updates prices)     By Sam Forgione     NEW YORK, Dec 22 Equity markets worldwide edged higher on Monday after rising expectations for more European stimulus supported shares in the region, while year-end buying underpinned U.S. stocks.     U.S. stocks i ~US STOCKS-Wall St on track for four-day rally; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates prices) ~U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks (Story refiles to correct typographical error in first paragraph to Sovaldi instead of Solvadi) ~US STOCKS-Wall St edges up after three-day run; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to afternoon trading) ~REFILE-UPDATE 2-U.S. FDA approves AbbVie hepatitis C drug, costs $83,319 for 12 weeks (Corrects typographical error in first paragraph to Sovaldi instead of Solvadi) ~Achillion data shows promise of shorter-duration hep C treatment Data from Achillion Pharmaceuticals Inc's hepatitis C drug trials showed the company could develop a shorter-duration treatment rivaling offerings from Gilead Sciences Inc and Abbvie Inc. ~
GS,Goldman sells Metro metals warehouse unit to Reuben Bros Goldman Sachs Group Inc has sold its controversial metals warehousing business to Swiss private equity group Reuben Brothers, the Wall Street bank said on Monday. ~UPDATE 2-Goldman sells Metro metals warehouse unit to Reuben Bros Dec 22 Goldman Sachs Group Inc has sold its controversial metals warehousing business to Swiss private equity group Reuben Brothers, the Wall Street bank said on Monday. ~Goldman sells Metro metals warehouse unit to Reuben Bros -CNBC Dec 22 Goldman Sachs Group Inc has sold its controversial metals warehousing business to Swiss private equity group Reuben Brothers, CNBC reported on Monday, citing a source familiar with the situation. ~
INTC.O,US STOCKS-Wall St up for fourth straight day; S&P; ends at record * Indexes up: Dow 0.9 pct, S&P; 0.4 pct, Nasdaq 0.3 pct   (Updates to close) ~US STOCKS-Wall St on track for four-day rally; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates prices) ~US STOCKS-Wall St edges up after three-day run; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to afternoon trading) ~
IBM,US STOCKS-Wall St up for fourth straight day; S&P; ends at record * Indexes up: Dow 0.9 pct, S&P; 0.4 pct, Nasdaq 0.3 pct   (Updates to close) ~US STOCKS-Wall St on track for four-day rally; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates prices) ~US STOCKS-Wall St edges up after three-day run; tech lifts Dow * Indexes up: Dow 0.6 pct, S&P; 0.1 pct, Nasdaq 0.2 pct   (Updates to afternoon trading) ~
LMT,UPDATE 1-Lockheed meets 2014 target for 36 F-35 deliveries-Pentagon WASHINGTON, Dec 22 Lockheed Martin Corp  met its target of delivering 36 F-35 fighter jets to the U.S. government in 2014, paving the way for the firm to collect most of the associated performance fees, a spokesman for the Pentagon's F-35 program office said Monday. ~Pentagon says Lockheed met target for 36 F-35 deliveries in 2014 WASHINGTON, Dec 22 Lockheed Martin Corp  met its target of delivering 36 F-35 fighter jets to the U.S. government in 2014, paving the way for the firm to collect most of the associated performance fees, a spokesman for the Pentagon's F-35 program office said Monday. ~
MS,Rosneft expansion thwarted by U.S. veto on Morgan Stanley deal MOSCOW The ambitions of Kremlin-controlled oil champion Rosneft to boost its global reach have been reined in by U.S. authorities, which torpedoed its acquisition of a Morgan Stanley oil trading business. ~UPDATE 2-Rosneft expansion thwarted by U.S. veto on Morgan Stanley deal * Rosneft shares closed up 2.5 percent   (Writes through, adds portfolio manager comment) ~Russia's Rosneft says trading deal with Morgan Stanley annulled MOSCOW Russia's top oil producer Rosneft  said on Monday that the deal to acquire an oil trading business from Morgan Stanley  has been terminated due to refusal from the United States' regulators to clear it. ~Russia's Rosneft says trading deal with Morgan Stanley annulled MOSCOW, Dec 22 Russia's top oil producer Rosneft  said on Monday that the deal to acquire an oil trading business from Morgan Stanley has been terminated due to refusal from the United States' regulators to clear it. ~
PG,P&G; to sell soap brands Camay and Zest to Unilever Procter & Gamble Co said it would sell its soap brands Camay and Zest to Unilever Plc for an undisclosed amount to focus on its faster-growing brands. ~P&G; to sell soap brands Camay and Zest to Unilever Procter & Gamble Co said it would sell its soap brands Camay and Zest to Unilever Plc for an undisclosed amount to focus on its faster-growing brands. ~UPDATE 1-P&G; to sell soap brands Camay and Zest to Unilever Dec 22 Procter & Gamble Co said it would sell its soap brands Camay and Zest to Unilever Plc for an undisclosed amount to focus on its faster-growing brands. ~P&G; to sell soap brands Camay and Zest to Unilever Dec 22 Procter & Gamble Co said it would sell its soap brands Camay and Zest to Unilever Plc for an undisclosed amount, to focus on its faster-growing brands. ~
RTN,Raytheon wins $491 mln U.S. contract for AMRAAM missiles WASHINGTON, Dec 22 Raytheon Co has won a contract valued at $491 million to continue production of its Advanced Medium Range Air to Air Missiles (AMRAAM) for the U.S. Air Force, the Pentagon announced Monday. ~
KO,Gaza gets machinery to equip its first Coca Cola plant GAZA/RAMALLAH, Dec 22 With Israel's approval, Palestinians began importing machinery on Monday to equip the Gaza Strip's first Coca Cola plant for an anticipated 2015 launch of operations. ~BRIEF-UK's CMA okays Coca-Cola and Monster Beverages deal * Has decided that a relevant merger situation has not been created in proposed transaction between the Coca-Cola Company and Monster Beverages  Source text for Eikon:  Further company coverage: [KO.N MNST.O]   (Bangalore Newsroom: +91 80 6749 1136) ~
TWX,UPDATE 1-U.S. FCC pauses Comcast-Time Warner merger review until Jan. 12 WASHINGTON U.S. Federal Communications Commission on Monday once again paused its review of the proposed $45 billion merger of Comcast Corp and Time Warner Cable Inc, citing delays in getting documents from Time Warner Cable. ~UPDATE 1-U.S. FCC pauses Comcast-Time Warner merger review until Jan. 12 (Adds comments from Time Warner Cable and Comcast, background) ~
WFC,FINRA bars ex-Wells Fargo broker for life for theft from client A former Wells Fargo Advisors broker in Chico, California, has been permanently barred from the industry for stealing almost $89,000 from an elderly customer, the U.S. securities industry's principal regulator of brokers said on Monday. ~FINRA bars ex-Wells Fargo broker for life for theft from client Dec 22 A former Wells Fargo Advisors broker in Chico, California, has been permanently barred from the industry for stealing almost $89,000 from an elderly customer, the U.S. securities industry's principal regulator of brokers said on Monday. ~
